Mackram F Eleid1, Hector I Michelena2, Vuyisile T Nkomo2, Rick A Nishimura2, Joseph F Malouf2, Christopher G Scott3, Patricia A Pellikka2. 1. Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA eleid.mackram@mayo.edu. 2. Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. 3. Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, MN, USA.
Abstract
AIMS: Reduced stroke volume index (SVI) in patients with severe aortic stenosis (AS) and preserved ejection fraction (EF) is associated with adverse outcomes even after aortic valve replacement (AVR), although specific reasons for impaired survival in this group are unknown. We investigated predictors of post-AVR survival and specific cause of death in patients with AS according to SVI. METHODS AND RESULTS: Among 1120 consecutive patients with severe AS (aortic valve area <1.0 cm(2)) and preserved EF (≥50%) using 2-D and Doppler echocardiography who had AVR, 61 (5%) patients had reduced SVI [<35 mL/m(2) (low flow, LF)] and 1059 (95%) had normal SVI [≥35 mL/m(2) (normal flow, NF)]. Survival post-AVR was lower in patients with LF compared with NF [3-year survival in LF group 76% (95% CI 70-82) vs. 89% (95% CI 88-90%), P = 0.03] primarily due to higher cardiac mortality [3-year event rate 13% (95% CI 8-18%) in LF vs. 5% (95% CI 5-7%) in NF, P = 0.02]. Congestive heart failure (CHF) was the most common cause of cardiac death in the LF group (57% of post-AVR cardiac deaths) and was a more frequent cause of death in LF compared with NF (3-year risk 7 vs. 2%, P = 0.008). Multivariable predictors of post-AVR mortality included age, creatinine, haemoglobin, right ventricular systolic pressure, SVI, and cognitive impairment. CONCLUSION: Reduced SVI is associated with higher cardiac mortality after AVR. CHF is the predominant cause of cardiac mortality after AVR in patients with LF, suggesting the presence of persistent myocardial impairment in this population. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Reduced stroke volume index (SVI) in patients with severe aortic stenosis (AS) and preserved ejection fraction (EF) is associated with adverse outcomes even after aortic valve replacement (AVR), although specific reasons for impaired survival in this group are unknown. We investigated predictors of post-AVR survival and specific cause of death in patients with AS according to SVI. METHODS AND RESULTS: Among 1120 consecutive patients with severe AS (aortic valve area <1.0 cm(2)) and preserved EF (≥50%) using 2-D and Doppler echocardiography who had AVR, 61 (5%) patients had reduced SVI [<35 mL/m(2) (low flow, LF)] and 1059 (95%) had normal SVI [≥35 mL/m(2) (normal flow, NF)]. Survival post-AVR was lower in patients with LF compared with NF [3-year survival in LF group 76% (95% CI 70-82) vs. 89% (95% CI 88-90%), P = 0.03] primarily due to higher cardiac mortality [3-year event rate 13% (95% CI 8-18%) in LF vs. 5% (95% CI 5-7%) in NF, P = 0.02]. Congestive heart failure (CHF) was the most common cause of cardiac death in the LF group (57% of post-AVR cardiac deaths) and was a more frequent cause of death in LF compared with NF (3-year risk 7 vs. 2%, P = 0.008). Multivariable predictors of post-AVR mortality included age, creatinine, haemoglobin, right ventricular systolic pressure, SVI, and cognitive impairment. CONCLUSION: Reduced SVI is associated with higher cardiac mortality after AVR. CHF is the predominant cause of cardiac mortality after AVR in patients with LF, suggesting the presence of persistent myocardial impairment in this population. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Iung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala Journal: Eur Heart J Date: 2012-08-24 Impact factor: 29.983
Authors: Vasileios Kamperidis; Philippe J van Rosendael; Arnold C T Ng; Spyridon Katsanos; Frank van der Kley; Philippe Debonnaire; Emer Joyce; Georgios Sianos; Nina Ajmone Marsan; Jeroen J Bax; Victoria Delgado Journal: Am J Cardiol Date: 2014-09-28 Impact factor: 2.778
Authors: Vuyisile T Nkomo; Julius M Gardin; Thomas N Skelton; John S Gottdiener; Christopher G Scott; Maurice Enriquez-Sarano Journal: Lancet Date: 2006-09-16 Impact factor: 79.321
Authors: Marie-Annick Clavel; Jean G Dumesnil; Romain Capoulade; Patrick Mathieu; Mario Sénéchal; Philippe Pibarot Journal: J Am Coll Cardiol Date: 2012-05-30 Impact factor: 24.094
Authors: Mackram F Eleid; Paul Sorajja; Hector I Michelena; Joseph F Malouf; Christopher G Scott; Patricia A Pellikka Journal: Heart Date: 2014-09-12 Impact factor: 5.994
Authors: Howard C Herrmann; Philippe Pibarot; Irene Hueter; Zachary M Gertz; William J Stewart; Samir Kapadia; E Murat Tuzcu; Vasilis Babaliaros; Vinod Thourani; Wilson Y Szeto; Joseph E Bavaria; Susheel Kodali; Rebecca T Hahn; Mathew Williams; D Craig Miller; Pamela S Douglas; Martin B Leon Journal: Circulation Date: 2013-05-09 Impact factor: 29.690
Authors: Bhuvnesh Aggarwal; Stephen G Ellis; A Michael Lincoff; Samir R Kapadia; Joseph Cacchione; Russell E Raymond; Leslie Cho; Christopher Bajzer; Ravi Nair; Irving Franco; Conrad Simpfendorfer; E Murat Tuzcu; Patrick L Whitlow; Mehdi H Shishehbor Journal: J Am Coll Cardiol Date: 2013-05-09 Impact factor: 24.094
Authors: Bo Fu; Shaopeng Zhang; Shilin Dai; Zhigang Guo; Nan Jiang; Jiange Han; Li Yang; Yanwen Shang; Yanhe Ma; Thomas Puehler; Rodrigo Bagur Journal: Ann Transl Med Date: 2021-08
Authors: Yan Fan; Hong Shen; Brandon Stacey; David Zhao; Robert J Applegate; Neal D Kon; Edward H Kincaid; Sanjay K Gandhi; Min Pu Journal: Int J Cardiovasc Imaging Date: 2021-08-14 Impact factor: 2.357
Authors: Altayyeb Yousef; Benjamin Hibbert; Joshua Feder; Jordan Bernick; Juan Russo; Zachary MacDonald; Christopher Glover; Alexander Dick; Munir Boodhwani; Buu-Khanh Lam; Marc Ruel; Marino Labinaz; Ian G Burwash Journal: PLoS One Date: 2018-04-26 Impact factor: 3.240